Here are four points:
1. Xtant’s total short interest was 79,800 shares in May as published by the Financial Industry Regulatory Authority.
2. Xtant Medical has underperformed the S&P500 by 43.12 percent.
3. The company’s average volume is 29,800 shares.
4. The company has a market cap of $21.56 million.
More articles on devices:
FDA clears First Ray’s Stealth Staple System — 5 highlights
Medtronic names Karen Parkhill EVP, CFO: 5 key notes
Siemens, Ziehm, GE, Hologic, OrthoScan & Medtronic: 26 O-arm & C-arm systems
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
